We are live on
!
Find out more
CCMD
Cypress Capital Management (Delaware) Portfolio holdings
AUM
$539M
1-Year Est. Return
11.57%
This Fund
S&P 500
This Quarter
Est. Return
-11.03%
1 Year Est. Return
-11.57%
3 Year Est. Return
+25.57%
5 Year Est. Return
+49.47%
10 Year Est. Return
–
AUM
$485M
AUM Growth
-$86.7M
(-15%)
Cap. Flow
-$20.3M
Cap. Flow
% of AUM
-4.19%
Top 10 Holdings %
Top 10 Hldgs %
33.1%
Holding
161
New
10
Increased
39
Reduced
43
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citizens Financial Group
CFG
|
+$8.06M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$5.82M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$5.67M |
| 4 |
Linde
LIN
|
+$781K |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$605K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$9.14M |
| 2 |
Weyerhaeuser
WY
|
+$8.57M |
| 3 |
AT&T
T
|
+$5.97M |
| 4 |
SLB Ltd
SLB
|
+$5.76M |
| 5 |
HBI
Hanesbrands
HBI
|
+$5.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.81% |
| 2 | Technology | 17.81% |
| 3 | Financials | 13.32% |
| 4 | Industrials | 9.78% |
| 5 | Miscellaneous | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merck
MRK
$366B
| $23.1M | 4.77% |
317,172
-1,810
| -0.6% | -$128K |
|
2
Microsoft
MSFT
$3.81T
| $20M | 4.14% |
197,361
+12
| +0% | +$1.28K |
|
3
Pfizer
PFE
$159B
| $18.2M | 3.76% |
440,101
-7,915
| -2% | -$329K |
|
4
Abbott
ABT
$195B
| $16.4M | 3.38% |
226,671
-3,868
| -2% | -$272K |
|
5
Cisco
CSCO
$433B
| $16.4M | 3.38% |
377,843
-1,390
| -0.4% | -$63.6K |
|
6
Johnson & Johnson
JNJ
$646B
| $15.2M | 3.14% |
117,858
+42
| +0% | +$5.86K |
|
7
DuPont de Nemours
DD
$18.5B
| $13.7M | 2.82% |
101,105
-6,283
| -6% | -$902K |
|
8
JPMorgan Chase
JPM
$951B
| $13.6M | 2.8% |
139,011
+1,587
| +1% | +$169K |
|
9
Apple
AAPL
$4.67T
| $12.2M | 2.52% |
309,420
+4,968
| +2% | +$241K |
|
10
Berkshire Hathaway Class B
BRK.B
$1.08T
| $11.6M | 2.4% |
56,940
+395
| +0.7% | +$82.5K |
|
11
Oracle
ORCL
$435B
| $11.5M | 2.37% |
254,630
-3,063
| -1% | -$147K |
|
12
Dominion Energy
D
$57.7B
| $10.8M | 2.23% |
151,225
+1,050
| +0.7% | +$76.7K |
|
13
Home Depot
HD
$329B
| $10.7M | 2.21% |
62,212
+902
| +1% | +$162K |
|
14
Mondelez International
MDLZ
$79.6B
| $10.4M | 2.15% |
260,323
-1,225
| -0.5% | -$52.2K |
|
15
Evergy
EVRG
$18.6B
| $10.2M | 2.11% |
179,900
-1,625
| -0.9% | -$93.8K |
|
16
RTX Corp
RTX
$285B
| $9.91M | 2.04% |
147,864
-278
| -0.2% | -$21.8K |
|
17
ExxonMobil
XOM
$644B
| $9.86M | 2.03% |
144,601
+49
| +0% | +$3.84K |
|
18
Boeing
BA
$166B
| $9.78M | 2.02% |
30,324
-155
| -0.5% | -$53.5K |
|
19
Agilent Technologies
A
$43.4B
| $9.6M | 1.98% |
142,308
| – | – |
|
20
Chevron
CVX
$396B
| $9.36M | 1.93% |
86,052
-190
| -0.2% | -$22K |
|
|
RTN
21
DELISTED
Raytheon Company
RTN
| $9.28M | 1.91% |
60,522
+411
| +0.7% | +$73.6K |
|
22
PNC Financial Services
PNC
$96.6B
| $9.05M | 1.87% |
77,438
-575
| -0.7% | -$73.4K |
|
23
HP
HPQ
$27.5B
| $8.93M | 1.84% |
436,596
-13,839
| -3% | -$323K |
|
24
Nutrien
NTR
$35.1B
| $8.92M | 1.84% |
189,696
-3,071
| -2% | -$160K |
|
25
Carnival Corporation Ltd
CCL
$33.9B
| $8.76M | 1.81% |
177,670
-15,300
| -8% | -$876K |
|
Similar funds
KPW
SIMS
RTS
KCM
MG
SMG
HPWM
RWA
Cypress Capital Management (Delaware)'s Q4 2018 Portfolio in Review
As of Q4 2018, Cypress Capital Management (Delaware) held 161 positions worth $485M, down 15% from $571M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Cypress Capital Management (Delaware) withdrew a net $20.3M in Q4 2018, closing 14 positions and reducing 43 holdings. Its most notable exit was Weyerhaeuser, an estimated $8.57M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Financials.
Against the trend, Cypress Capital Management (Delaware) opened a new position in Citizens Financial Group worth $6.83M.
- Cypress Capital Management (Delaware)'s largest Q4 2018 buy was Citizens Financial Group: 229,850 shares worth $6.83M.
- Cypress Capital Management (Delaware) added most to Bristol-Myers Squibb in Q4 2018, an estimated $5.82M increase.
- Cypress Capital Management (Delaware)'s biggest Q4 2018 reduction was Procter & Gamble, cutting an estimated $9.14M.
- Cypress Capital Management (Delaware) fully exited Weyerhaeuser in Q4 2018, selling an estimated $8.57M.
- Cypress Capital Management (Delaware)'s ten largest holdings make up 33% of its $485M portfolio in Q4 2018.
- Cypress Capital Management (Delaware) opened 10 new positions and closed 14 in Q4 2018.
- Cypress Capital Management (Delaware)'s portfolio value fell 15% quarter-over-quarter to $485M.
Based on Cypress Capital Management (Delaware)'s 13F filing for Q4 2018, filed 5 Feb 2019.